Clinical Trials
2 trialsNCT05504278 2025-01-27
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Recruiting
NCT00349219 2016-01-15
TORCH
National Cancer Institute, Naples
Phase 3 Completed